[1]
Pankaj Kumar Singh and Sameer Kumar, “Comparative Study to Evaluate Efficacy & Cost Effectiveness of Olmesartanversus Telmisartan, In Patients of Stage I Hypertension”, AJMR, vol. 9, no. 1, pp. PC01-PC06, Apr. 2020.